男，35岁，中国药科大学药剂学专业博士毕业，现任徐州医科大学、江苏省新药与临床药学重点实验室副教授，中国药学会制药工程委员会青年委员，江苏省药理学会会员，徐州市生态健康协会理事，江苏省科技副总。长期从事医药产品及其相关化妆品、功能食品的研究和开发。先后参与863计划、国家重大新药创制项目等国家及省部级项目近10项，主持国家自然科学基金项目等项目5项。承接企事业单位委托研发项目近10项，完成药品、消毒产品以特医食品等近10项产品的开发。发表论文近30篇，其中SCI论文10余篇，授权专利5项。

 

近5年的3篇代表性论著：

1)        Meng Jian, Li Lei, Wei Xiangrong, Chen Du, Chen Congliang, Liu Shuo, Wang Ziyao, Shi Guangwei, Wang Shoupeng, Zhou Xiaokai, Jiang Li Qun*. A simple liposome-based bionic bacterium for tumor treatment by re-education of tumor-associated microphages in combination with chemotherapy. Colloids and Surfaces B: Biointerfaces, 2023, in press. (期刊论文, IF=5.99)

2)        Jiang Li Qun; Wang Yun; Wei Xiang Rong; Yang Ling; Liu Shuo; Wang Yan; Xu Ya; Wang Zi Yao; Zhang Cong; Zhang Mi; Zhang Yu Dong; Jin Fang; Yin Xiao Xing; Improvement in phenotype homeost asis of macrophages by chitosan nanoparticles and subsequent impacts on liver injury and tumor treatment, Carbohydrate Polymers, 2022, 277: 118891. (期刊论文, IF=10.723)

3)        Jiang Li Qun; Zhang Mi; Bai Yu Ting; Cui Fei Yan; Zhang Cong; Wang Zi Yao; Si Su Jia; Yan g Ling; Wang Yun; Zhang Yu Dong; Li Lei; Liu Shuo; Wei Xiang Rong; Wang Yan; Xu Ya; Meng Jian; O-carboxymethyl chitosan based pH/hypoxia-responsive micelles relieve hypoxia and induce ROS in tu mor microenvironment, Carbohydrate Polymers, 2022, 275: 118611. (期刊论文, IF=10.723)

 

近5年内发表的其它论著：

1)        Qin Xichun; Zhou Yeqing; Wang Yuzhuo; Wang Ziyao; Wang Yun; Chen Jiali; Zhu Lidong; Quan Xiaoyu; Liu Zhiwei; Zhang Hao; Jiang Li Qun*; Dong Hongyan*; Zhang Zhongming*; Preparation and Characterization of Protein-loaded PFC Nanoemulsions for the Treatment of Heart Diseases by Pulmonary Administration, European Journal of Pharmaceutical Sciences, 2021, 158:  105690. (期刊论文, IF=5.112)

2)        Jiang, Li Qun; Wang, Ting Yu; Wang, Yun; Wang, Zi Yao; Bai, Yu Ting ; Co-disposition of c hitosan nanoparticles by multi types of hepatic cells and their subsequent biological elimination: the mechanism and kinetic studies at the cellular and animal levels, International Journal of N anomedicine, 2019, 14: 6035-6060. (期刊论文, IF=7.033)

3)        Jiang Li Qun; Duan Huajian; Ji Xiangxiang; Wang Tingyu; Wang Yun; Qiu Jingying ; Application of a simple desolvation method to increase the formation yield, physical stability and hydrophobic drug encapsulation capacity of chitosan-based nanoparticles, International Journal of Pharmaceutics, 2018, 545(1-2): 117-127. (期刊论文, IF=6.510)

4)        Jiang, Li Qun; Wang, Ting Yu; Webster, Thomas J.; Duan, Hua-Jian; Qiu, Jing Ying; Zhao, Zi Ming; Yin, Xiao Xing; Zheng, Chun Li ; Intracellular disposition of chitosan nanoparticles in macrophages: intracellular uptake, exocytosis, and intercellular transport, International Journal of Nanomedicine, 2017, 12: 6383-6398. (期刊论文, IF=7.033)

 

5年以外的代表性论著：

1)        Jiang Li Qun, Zhao Xin, Zheng Chunli, Li Fang, Maclean James L, Chen Fangcheng, Swami Archana, Qian Hai, Zhu Jiabi, Ge Liang*. The quantitative detection of the uptake and intracellular fate of albumin nanoparticles. RSC Advances, 2015, 5(44): 34956-34966. (期刊论文, IF=4.036)

2)        Jiang Li Qun, Xu Yi Sheng, Liu Qi, Tang Yue, Ge Liang, Zheng Chun Li, Zhu Jia Bi, Liu Jian Ping*. A nontoxic disulfide bond reducing method for lipophilic drug-loaded albumin nanoparticle preparation: formation dynamics, influencing factors and formation mechanisms investigation. International Journal of Pharmaceutics, 2013, 443(1-2): 80-86. (期刊论文, IF=6.510)

3)        Jiang Li Qun, Tang Yue, Zhang Hong Jiu, Lu Xi Feng, Chen Xi Jing, Zhu Jia Bi*. Importance of powder residence time for the aerosol delivery performance of a commercial dry powder inhaler Aerolizer?. Journal of aerosol medicine and pulmonary drug delivery. 2012,25:265-79. (期刊论文, IF=3.440)

4)        姜力群,丁哲靖,王婷玉,孙蓉,陈小龙,徐伟,许葱葱,郑春丽,朱家壁.基于FRET效应对纳米递药系统胞内释药检测方法的建立[J].中国新药杂志,2016,25(23):2737-2744. (期刊论文)

5)        姜力群,王婷玉,许小艺,朱伊婷,刘子琪,刘振南,陈稀琪,郑春丽,朱家壁.一种纳米粒细胞动力学的生理药动学模型的建立与解析[J].中国医院药学杂志,2016,36(19):1645-1650. (期刊论文)

姜力群,葛志华,王婷玉.用于纳米递药系统荧光标记的3种CdTe量子点荧光特性的比较[J].中国医药工业杂志,2016,47(06):723-727+750. (期刊论文) 

 

1)        中国发明专利, 姜力群, 印晓星, 许亚, 魏相荣, 司苏佳. 一种用于预防和治疗高原肺水肿的间充质干细胞杂化胞外囊泡的制备方法,申请, CN2022101499469.

2)        中国发明专利, 董红燕, 姜力群, 秦西淳, 陈佳丽, 刘志伟, 张中明. 一种呼吸道给药的药物载体、其制备方法及其在制备治疗心脏病药物中的应用,授权,CN 201910330644X.

3)        中国发明专利, 董红燕, 秦西淳, 姜力群, 张中明, 陈佳丽, 刘志伟, 朱立东. PEDF衍生多肽组合物及其在制备保护肺损伤药物中的应用,实审, CN2019107583013.

4)        中国发明专利, 董红燕, 秦西淳, 姜力群, 张中明. PEDF在制备保护肺损伤药物中的应用,实审, CN 202010716340X.

5)        中国发明专利, 姜力群, 王云, 白玉婷, 王子尧, 杨玲, 张咪, 周峰, 张召辉. 一种治疗肝脏缺血再灌注损伤的药物组合物及其制备方法,实审, CN201911165406.4.

6)        中国发明专利, 姜力群，孙恬，周琼，王先航，王云. 一种吸气触发的且具计数功能的气雾剂吸入装置, 实审, CN 201811304945.7

7)        中国发明专利，姜力群，崔飞艳，孟箭，王子尧，杨玲，张咪，王云. 一种制备治疗干槽症的复合海绵的方法, 授权, CN 202011072003.8.

8)        中国发明专利, 姜力群, 白玉婷, 孟箭, 王云, 王子尧, 李蕾, 崔飞燕, 杨玲, 张咪. 一种改善口腔癌肿瘤微环境并抑制肿瘤生长的复合胶束及其制备方法,授权,CN 202010264607.6.